David Nikodem
Vorstandsvorsitzender bei ALTHEADX INC
Aktive Positionen von David Nikodem
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALTHEADX INC | Direktor/Vorstandsmitglied | 01.12.2015 | - |
Vorstandsvorsitzender | 01.12.2018 | - | |
INVENTIVA | Corporate Officer/Principal | 01.09.2018 | - |
Sapidus Consulting Group LLC | Corporate Officer/Principal | - | - |
Karriereverlauf von David Nikodem
Ehemalige bekannte Positionen von David Nikodem
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Trading-Equity | 06.09.2005 | 30.12.2007 |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Analyst-Equity | 01.01.2002 | 31.08.2005 |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 30.09.2015 | - |
CG ONCOLOGY, INC. | Direktor/Vorstandsmitglied | - | - |
ALZHEON, INC. | Direktor/Vorstandsmitglied | 01.12.2014 | - |
Independent Dir/Board Member | 01.12.2014 | - | |
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Portfolio Manager-Aktien | 01.01.2010 | - |
Ausbildung von David Nikodem
Georgetown University | Doctorate Degree |
University of Virginia | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Frankreich | 3 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Analyst-Equity | 1 |
Sektoral
Health Technology | 6 |
Finance | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CG ONCOLOGY, INC. | Health Technology |
INVENTIVA | Health Technology |
Private Unternehmen | 7 |
---|---|
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Finance |
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Finance |
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Finance |
Alzheon, Inc.
Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Health Technology |
AltheaDx, Inc.
AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA. | Health Technology |
Sapidus Consulting Group LLC |
- Börse
- Insiders
- David Nikodem
- Erfahrung